Abstract: A technique comprising: assembling together a front plane (1) comprising a first flexible substrate (4) supporting a display medium (6a) and a backplane (2) comprising a second flexible substrate (8) supporting an array of electronic elements (9) for controlling said display medium; and creating an electrically conductive connection between first and second conductive elements (5 10) on opposing faces of the frontplane and backplane by sandwiching an electrically conductive structure (3) between the frontplane and backplane in the region of the first and second conductive elements, wherein the conductive structure is at least more flexible than the least flexible one of the front plane and backplane.

Abstract: A method for unloading inventory items includes storing an inventory item on an inventory holder and moving the inventory holder toward an unloading station with a mobile drive unit. Additionally, the method includes moving the inventory holder past a barrier of the unloading station. The method further includes preventing the inventory item from moving past the barrier as the mobile drive unit moves the inventory holder past the barrier.

Abstract: A composition for the intranasal delivery of fentanyl or a pharmaceutically acceptable salt thereof to an animal includes an aqueous solution of fentanyl or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable additive selected from (i) a pectin and (ii) a poloxamer and chitosan or a salt or derivative thereof; provided that when the composition comprises a pectin it is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (Cmax) that is from 10 to 80% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose. A method for treating or managing pain by intranasally administering the composition is also disclosed.

Abstract: 6-M ethyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form.

Abstract: An intranasnal spray device contains a composition for the intranasal delivery of fentanyl or a pharmaceutically acceptable salt thereof to an animal includes an aqueous solution of fentanyl or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable additive selected from (i) a pectin and (ii) a poloxamer and chitosan or a salt or derivative thereof; provided that when the composition comprises a pectin it is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (Cmax) that is from 10 to 80% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose. A method for treating or managing pain by intranasally administering the composition is also disclosed.

Abstract: An auditing system is disclosed comprising a Policy Validation Mechanism Program (PVMP) that operates in conjunction with a Workflow Engine (WE), and a Policy Validation Server Program (PVSP) that operates on a Policy Validation Server (PVS) connected to the WE by a secure communication link. The PVMP converts a workflow to a workflow representation (WR) and sends the WR to the PVS. The PVSP compares the steps in the WR to a security policy identified for that WR and determines whether the WR is in compliance. In addition, the PVSP validates a checksum for the WR and logs the checksum for subsequent comparisons. The PVSP uses the checksum to determine whether a policy has changed during execution of the workflow.

Abstract: 6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form.

Abstract: A method and computer usable program product for generating meal plans based on a set of nutritional policies. The process determines nutritional requirements specified by a set of nutritional policies in response to receiving a request for a set of meal plans for a set of users. The set of nutritional policies correspond to the set of users. The process identifies a set of potential meal plans in response to determining the nutritional requirements specified by the set of nutritional policies. Each potential meal plan in the set of potential meal plans satisfies all nutritional requirements for the set of nutritional policies. The process generates a listing of ingredients required by the selected meal plan that is unavailable in a current inventory in an amount required by the selected meal plan, in response to receiving a selection of a potential meal plan to form a selected meal plan.

Abstract: An auditing system is disclosed comprising a Policy Validation Mechanism Program (PVMP) that operates in conjunction with a Workflow Engine (WE), and a Policy Validation Server Program (PVSP) that operates on a Policy Validation Server (PVS) connected to the WE by a secure communication link. The PVMP converts a workflow to a workflow representation (WR) and sends the WR to the PVS. The PVSP compares the steps in the WR to a security policy identified for that WR and determines whether the WR is in compliance. In addition, the PVSP validates a checksum for the WR and logs the checksum for subsequent comparisons. The PVSP uses the checksum to determine whether a policy has changed during execution of the workflow. If the WR is not in compliance, if the checksum cannot be validated, or if a policy has changed, then a failure notification is sent to the WE. Otherwise, a success notification is sent to the WR.

Abstract: A composition for the intranasal delivery of fentanyl or a pharmaceutically acceptable salt thereof to an animal includes an aqueous solution of fentanyl or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable additive selected from (i) a pectin and (ii) a poloxamer and chitosan or a salt or derivative thereof; provided that when the composition comprises a pectin it is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (Cmax) that is from 10 to 80% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose. A method for treating or managing pain by intranasally administering the composition is also disclosed.

Abstract: A method, computer program product, and system are disclosed for installing a patch on at least some of the servers of a network having multiple servers. A plurality of servers of the network are identified that requires installation of the patch. Two or more priority values are assigned to each of the identified servers. The priority values for a given identified server are each associated with a different criterion in a set of criteria. The assigned priority values are selectively processed for respective identified servers, in order to determine an initial priority, comprising a first sort order, for installing the patch on each identified server. The first sort order is revised in accordance with information pertaining to prior use of respective identified servers, to provide a second sort order. The patch is installed on each of the identified servers, in an order determined by the second sort order.

Abstract: A low noise axial flow impeller has a multi cellular form of construction comprising a multiplicity of individual axial flow channels disposed in a circumferential and radial array with respect to the axis of rotation. This increases the “blade passing frequency” as compared to a conventional impeller and since higher frequencies have lower energy for a given flow output the total amplitude of the noise generated can be reduced. For high total flow area coupled with low structural weight the channels are arranged in tessellating rings of equal numbers of channels, with channel cross sections based on hexagons (or truncated hexagons in the case of the channels in the innermost and outermost rings).

Abstract: The present invention provides compositions for the intranasal administration of zolpidem or a pharmaceutically acceptable salt thereof. Preferred compositions of the invention are in the form of aqueous solutions. Optionally the compositions of the invention comprise a cyclodextrin and/or chitosan, a salt or derivative thereof or a salt of a derivative of chitosan. The compositions can be used for the treatment or prevention insomnia or the treatment of neurological disorders such as those arising from brain trauma, stroke and spinocerebellar ataxia or in the treatment of Parkinson's disease.

Abstract: A method, apparatus, and computer usable program product for mapping a content description to a container. The process identifies a container placed in a storage unit to form an identified container. The identified container includes an unidentified content. The process displays a set of predictive content descriptions for the unidentified content. In response to receiving a selection of a content description from the set of predictive content descriptions, the process maps the selected content description to the unidentified container.

Abstract: A forwarder for use within an internetworking system operating over an ATM backbone is provided. The physical internetworking devices within the system are shared to provide the internetworking functions while servicing two or more distinct and isolated user networks. This is accomplished by logically partitioning the devices into distinct sub-elements which provide all or part of the internetworking functions. These sub-elements are uniquely allocated to independent realms which are then assigned to specific user networks.

Abstract: Liquid pharmaceutical compositions for administration to a mucosal surface, including a therapeutic agent and a pectin with a low degree of esterification are described. Such compositions gel, or can be adapted to gel, at the site of application in the absence of an extraneous source of divalent metal ions.

Abstract: Embodiments of the present invention provide a computer implemented method, apparatus, and computer program product for estimating, refining, and using the tare mass for an item to determine and monitor item depletion. In response to detecting an initial presence of an item in the storage unit, a controller collects data about the item. The controller then searches a database for a recorded item containing the same item identification. The tare mass of the item is set equal to the refined tare mass of the recorded item retrieved from the database. The tare mass is then used to calculate a depletion threshold for the item.

Abstract: An internetworking system operating over an ATM backbone. The physical internetworking devices within the system are shared to provide the internetworking functions while servicing two or more distinct and isolated user networks. This is accomplished by logically partitioning the devices into distinct sub-elements which provide all or part of the internetworking functions. These sub-elements are uniquely allocated to independent realms which are then assigned to specific user networks.

Abstract: A computer implemented method, apparatus, and computer program product for communicating the shelf position of an item within a storage unit. An item to be located in the storage unit is identified. The storage unit system determines the shelf position of the identified item. The system then communicates the shelf position of the identified item to the user. If the user requests multiple items, the optimal sequence of retrieval for the items is determined based on a user configurable algorithm.

Abstract: Compositions are provided for the intranasal administration of granisetron or a pharmaceutically acceptable salt thereof. Preferred compositions are in the form of an aqueous solution. Optionally, the compositions comprise chitosan, a salt or derivative thereof or a salt of a derivative of chitosan. The compositions can be used for the treatment or prevention of nausea and/or vomiting.